Back to MBRXView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
1 competitor in Acute Myeloid Leukaemia (AML)
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Liposomal Annamycin Injection in combination with Cytarabine InjectionPhase 3
Acute Myeloid Leukaemia (AML)
Liposomal Annamycin (L-Annamycin)Phase 2
Sarcoma,Soft Tissue
Liposomal AnnamycinPhase 2
Leukemia, Myeloid, Acute
MOL4239Phase 2
Psoriasis
STAT3 Inhibitor WP1066Phase 2
Glioblastoma, IDH-Wildtype
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts